We are live on ! Find out more
CMPI

Checkmate Pharmaceuticals, Inc. Common Stock
CMPI

Delisted

CMPI was delisted on the 27th of May, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 26 → 0 (-26)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $54.8M → $0 (-$54.8M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 26

Holders
–
Holders Change
-26
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
MVM
Medicxi Ventures Management
Jersey
-$12.5M
2
VP
venBio Partners
California
-$11.7M
3
SI
Sofinnova Investments
California
-$11.5M
4
NHAS
Novo Holdings A/S
Denmark
-$6.9M
5
OFM
Omega Fund Management
Massachusetts
-$4.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
VP
1
venBio Partners
California
– -$11.7M -3,673,374 Closed
SI
2
Sofinnova Investments
California
– -$11.5M -3,606,707 Closed
NHAS
3
Novo Holdings A/S
Denmark
– -$6.9M -2,161,990 Closed
MVM
4
Medicxi Ventures Management
Jersey
– -$12.5M -1,501,716 Closed
OFM
5
Omega Fund Management
Massachusetts
– -$4.26M -1,335,050 Closed
DCMIC
6
Decheng Capital Management III (Cayman)
Cayman Islands
– -$4.25M -1,333,254 Closed
CCP
7
Clough Capital Partners
Massachusetts
– -$3.63M -1,137,764 Closed
Fidelity Investments
8
Fidelity Investments
Massachusetts
– -$3.08M -966,226 Closed
Vanguard Group
9
Vanguard Group
Pennsylvania
– -$1.77M -556,423 Closed
SAM
10
Sectoral Asset Management
Quebec, Canada
– -$1.73M -541,765 Closed
BCM
11
Bridgeway Capital Management
Texas
– -$340K -106,500 Closed
RC
12
RBF Capital
California
– -$219K -68,034 Closed
BlackRock
13
BlackRock
New York
– -$164K -51,334 Closed
Geode Capital Management
14
Geode Capital Management
Massachusetts
– -$132K -41,466 Closed
Federated Hermes
15
Federated Hermes
Pennsylvania
– -$98K -30,636 Closed
CT
16
Cambridge Trust
Massachusetts
– -$79K -24,609 Closed
Barclays
17
Barclays
United Kingdom
– -$46K -14,553 Closed
State Street
18
State Street
Massachusetts
– -$36K -11,424 Closed
Morgan Stanley
19
Morgan Stanley
New York
– -$10K -3,005 Closed
US Bancorp
20
US Bancorp
Minnesota
– -$6K -2,000 Closed
TRCT
21
Tower Research Capital (TRC)
New York
– -$6K -1,940 Closed
JMF
22
Johnson Midwest Financial
Iowa
– -$1K -200 Closed
UBS Group
23
UBS Group
Switzerland
– -$1K -183 Closed

CMPI Hedge Fund Activity: Q2 2022 in Review

0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) for Q2 2022, worth a combined $0 — down 100% from $54.8M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of CMPI and 0 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Medicxi Ventures Management, exiting entirely with an estimated $12.5M sold.

  • 0 institutional investors held Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) as of Q2 2022, down from 26 in Q1 2022.
  • Funds reported $0 of Checkmate Pharmaceuticals, Inc. Common Stock stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Checkmate Pharmaceuticals, Inc. Common Stock positions in Q2 2022 and 26 closed out, a net change of -26 holders.
  • The largest Checkmate Pharmaceuticals, Inc. Common Stock seller in Q2 2022 was Medicxi Ventures Management, an estimated $12.5M sold.

Based on aggregated 13F filings for Q2 2022.